A Phase I safety, tolerability, and pharmacokinetics study of SPR994, an orally administered carbapenem antibiotic in healthy subjects.

Trial Profile

A Phase I safety, tolerability, and pharmacokinetics study of SPR994, an orally administered carbapenem antibiotic in healthy subjects.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 24 Oct 2017

At a glance

  • Drugs Tebipenem pivoxil (Primary)
  • Indications Haemophilus infections; Streptococcal infections; Urinary tract infections
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 24 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top